Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124904633 | 12490463 | 3 | F | 20160628 | 20160622 | 20160711 | PER | JP-AMGEN-JPNCT2016014770 | AMGEN | 0.00 | F | Y | 55.00000 | KG | 20160710 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124904633 | 12490463 | 1 | PS | panitumumab | PANITUMUMAB | 1 | Intravenous drip | 320 MG, Q2WK | 125147 | 320 | MG | SOLUTION FOR INJECTION | QOW | ||||||
| 124904633 | 12490463 | 2 | C | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous drip | 120 MG, Q2WEEKS | U | 0 | 120 | MG | QOW | ||||||
| 124904633 | 12490463 | 3 | C | CALCIUM LEVOFOLINATE | LEVOLEUCOVORIN CALCIUM | 1 | Intravenous drip | 300 MG, Q2WEEKS | U | 0 | 300 | MG | QOW | ||||||
| 124904633 | 12490463 | 4 | C | CALCIUM LEVOFOLINATE | LEVOLEUCOVORIN CALCIUM | 1 | Intravenous drip | UNK UNK, Q2WEEKS | U | 0 | QOW | ||||||||
| 124904633 | 12490463 | 5 | C | 5-FU /00098801/ | FLUOROURACIL | 1 | Intravenous bolus | 600 MG, Q2WK | U | 0 | 600 | MG | QOW | ||||||
| 124904633 | 12490463 | 6 | C | 5-FU /00098801/ | FLUOROURACIL | 1 | Intravenous drip | 3650 MG, Q2WEEKS | U | 0 | 3650 | MG | QOW |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124904633 | 12490463 | 1 | Colon cancer |
| 124904633 | 12490463 | 2 | Colon cancer |
| 124904633 | 12490463 | 3 | Colon cancer |
| 124904633 | 12490463 | 5 | Colon cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124904633 | 12490463 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124904633 | 12490463 | Alopecia | |
| 124904633 | 12490463 | Constipation | |
| 124904633 | 12490463 | Decreased appetite | |
| 124904633 | 12490463 | Dermatitis acneiform | |
| 124904633 | 12490463 | Diarrhoea | |
| 124904633 | 12490463 | Dry skin | |
| 124904633 | 12490463 | Dysgeusia | |
| 124904633 | 12490463 | Hypokalaemia | |
| 124904633 | 12490463 | Hypomagnesaemia | |
| 124904633 | 12490463 | Nausea | |
| 124904633 | 12490463 | Palmar-plantar erythrodysaesthesia syndrome | |
| 124904633 | 12490463 | Peripheral sensory neuropathy | |
| 124904633 | 12490463 | Pigmentation disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124904633 | 12490463 | 1 | 20151203 | 0 | ||
| 124904633 | 12490463 | 2 | 20151203 | 20160330 | 0 | |
| 124904633 | 12490463 | 3 | 20151203 | 20160330 | 0 | |
| 124904633 | 12490463 | 4 | 20160420 | 0 | ||
| 124904633 | 12490463 | 5 | 20151203 | 0 | ||
| 124904633 | 12490463 | 6 | 20151203 | 0 |